Agilent Cytation 9 Cell Imaging Multimode Reader, or equivalent instrument

The U.S. Food and Drug Administration (FDA) is seeking information from potential vendors about their ability to provide an Agilent Cytation 9 Cell Imaging Multimode Reader or equivalent instrument. The system should have automated high-throughput image acquisition and analysis capabilities, configurable upright and inverted microscopy, and filter- and monochromator-based multimode microplate reading. The system will be used for screening applications, development, evaluation, and validation of New Approach Methodologies (NAMs). Key features include: • Automated digital microscopy and multimode detection in one system • Compatibility with 6 to 384-well microplates, microscope slides, and counting chambers • Fluorescence, brightfield, color brightfield, phase contrast, and high-contrast brightfield imaging modes • Ability to integrate with available automated incubator for live cell imaging workflows • End-point, time lapse, Z-stack, and montage imaging methods The FDA is seeking capability statements from vendors that can provide this system, including information about their company, past performance, and technical capabilities.